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T cells,  defined as the class of peripheral lymphocytes which carry Thy-1 cell surface 
antigens,  are  involved in  virtually  all  immune  responses.  In addition  to  serving  as 
precursors and effectors in cellular immunity, these cells play key regulatory roles in 
both humoral and cellular immunity. A series of different T cells, however, are responsi- 
ble for these various functions. These belong to different subclasses identifiable by cell 
surface antigenic characteristics (1-5). 
Surface markers used to identify T-cell subclasses include the presence of Ly-1 or Ly- 
2,3 antigens (1-4) and the presence of Fc receptors (FcR) 1 which bind antigen-antibody 
complexes  (6-8).  The Ly-l+,2-,3  -  (Ly-1) subclass contains amplifier cells for cytotoxic 
responses, helper cells for humoral responses  (Th),  and cells that initiate delayed-type 
hypersensitivity (1, 2). The presence of FcR further subdivides this subclass. Ly-1 FcR  + 
cells amplify cytotoxic responses; Ly-1 FcR- cells help secondary IgG humoral responses 
(6, 8). 
The Ly-l-,2÷,3  ÷ (Ly-2) subclass contains the precursors and effector cells for cellular 
immunity (2). It also contains the allotype suppressor T  cells  (Ts) used in the studies 
reported  here  (5), which  suppress  production  of IgG~  antibodies  carrying the  Ig-lb 
allotype in (BALB/c x  SJL)FI mice (9). The Ly-2 subclass is also subdivided according to 
presence of Fc receptors. The precursor for cytotoxic responses is Ly-2 FcR-; however, the 
cytotoxic effector cell is Ly-2 FcR  + (2, 8). 
B cells also carry identifying cell surface markers, some of which functionally subdi- 
vide B-cell  populations.  All B cells,  by definition,  carry surface immunoglobulin (10) 
which indicates  the  antibody-combining site  commitment of the  cell  and its progeny 
antibody-forming cells (afc) (11). Memory B cells carry surface IgG which indicates class 
and allotype commitment as well (11). 
Most B cells also carry easily detectable Ia determinants  (12-14),  although a  B-cell 
subset which carries little or no Ia has been identified and shown to give rise only to IgM 
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arc (Press,  personal communication [15]).  These la  determinants are controlled  by genes 
in the ! region of the major histocompatibility  complex (H-2) (16).  Loci that  control 
immune responses (It)  to a variety  of  antigens also  map in the I region  and thus are 
closely  linked  (or  identical)  with the loci  that control  B-cell  la determinants (16,  17). 
The T-cell surface markers have been used both to isolate  T  cells  with different 
functions  and to  identify  the  roles  that  these  cells  play in  the immune response (I-8).  For 
example,  in studies on the mechanism  of allotype  suppression, the difference  in Ly 
phenotypes between Ts and Th was crucial  for  showing that  Ts  are  different  from Th, and 
that Ts suppress production of  antibodies  carrying the Ig-lb allotype  by removing Th 
activity  capable of  helping !g-lb  memory B cells  (5). 
Using allotype  Ts, we have now characterized  a new set  of  T-cell  surface  determinants 
(15,  18)  which, like  Ly, distinguish  between Th and Ts populations.  Unlike Ly, however, 
these new T-cell  surface  determinants  are ceded for by loci  in the I region  of  the H-2 
complex. Their selective  expression  on Ts or  Th suggests  they may be directly  related  to 
the immunoregulatory functions  associated  with this  chromosomal region. 
The presence of/-region  determinants on  mouse peripheral  T cells  was  first  detected  by 
serologic  studies (14,  19).  Later, functional  studies  showed that anti-I-region  antisera 
blocked antigenic  stimulation  of  T cells  (20),  and that cytotoxic  treatment with  I-region 
antisera  kills  the T cells  which suppress idiotype  (21)  or allotype  (15,  18)  production.  In 
addition,  I-region  incompatible T cells  have been shown to stimulate mixed lymphocyte 
reactions (22).  /-region antisera have also  been shown to both block the binding of 
antigen-antibody  complexes  to  the  Fc  receptors  on  a substantial  proportion  ofFcR  +  T cells 
(15) and to kill the T  cells  which initiate  (promote) the overall T-cell  response to 
concanavalin A (Con A) (23).  Soluble  T-cell  factors  with helper (24,  25)  or  suppressor (26, 
27) activities  have also  been shown to carry  I-region  determinants. 
In this publication, we will show that Ts and Th carry  I-region determinants. 
We will also show that different antisera kill  Th or Ts, and thus, that each of 
these cell  types selectively express determinants that identify functional T-cell 
subpopulations.  In an accompanying  publication,  we will show that the Ts 
determinants are different from the B-cell  I-region (la)  determinants and are 
controlled by a new locus,  la-4,  which maps in a previously undefined segment 
of  the I-region provisionally designated the l-J subregion (28). 
Materials  and Methods 
Mice.  (BALB/cNHZ  x  SJL/JHz)F1 hybrids  (Ig~/Ig b, H-2't/H-2 ") and  BALB/cNHz mice were 
used  for  the  suppression  assay  and  helper  assay  experiments  reported  here.  Strains  used  to 
prepare  anti-Ia  sera  and  for absorption  studies  were BIO/Sn(H-2O),  BIO.D2/nSn(H-2d),  B10.A/ 
Sn(H-2~),  HTI/BoySf(H-29,  BIO.A(5R)/Sg(H-2~5),  A.TL/Sf(H-2tD,  A.TH/Sf and B10.S(7R)/Sg(H- 
2t2), BIO.HTT/Ph(H-2t3),  B10.AQR(N4)/Klj,  (H-2~J~), BIO.T(6R)/Sg(H-2~'z). 
Media.  Dulbecco's phosphate-buffered saline, pH 7.5 (29), supplemented with 5% heat-inacti- 
vated fetal calf serum was used for cell transfers.  Spleen cells to be tested for the presence of 
plaque-forming cells (PFC) were suspended in modified Eagle's medium with Hanks' balanced salt 
solution (Grand Island Biological Company, Grand Island, New York). 
Antigens.  Keyhole limpet hemocyanin  (KLH) (Pacific Biomarine Supply Company,  Venice, 
Calif.  was dialyzed  24  h  against  0.15  M  NaC1  and  then  centrifuged  at  10,000  rpm  to remove 
precipitated protein. The resulting supernate was then centrifuged at 30,000 rpm in a fixed-angle 
rotor for 2 h to pellet the protein, and the pellet was resuspended in 0.01 M cacodylate buffer, pH 
6.8. 
DNPs-KLH (per  10  '~ daltons)  was prepared  by reacting dinitrofiuorobenzene in 40-fold molar 
excess  with  the  carrier  protein  for  3  h  at  pH  8.2  in  0.5  M  NaHCO.~  buffer  (30). Free  2,4- 
dinitrophenol  (DNP)  was removed by extensively dialyzing the conjugates  against  phosphate- 
buffered saline (0.01  M phosphate,  pH 7.1,  in 0.15 M NaC1). OKUMURA,  HERZENBERG,  MURPHY,  McDEVITT,  AND  HERZENBERG  687 
Donors for Cell Transfer Experiments.  Nonsuppressed donors in adoptive cell transfers were 
obtained from matings between SJL/JHz males and BALB/cNHz females. Suppressed donors were 
obtained from matings between SJL/JHz males and BALB/cNHz females immunized against the 
paternal Ig-lb allotype (9).  Suppressed mice were 6-12-mo old when used and had no detectable 
serum Ig-lb at time of transfer. To purify T cells from these spleen cells, the nylon wool column 
method was used (31). 
Priming.  DNP-KLH-primed mice received 100 tLg DNP-KLH on alum plus 2 ×  10  ~ heat-killed 
Bordetella pertussis (kindly supplied by Lederle Laboratories,  Division of American Cyanamid 
Company, Pearl River, N. Y.) at least 8 wk before use as donors in adoptive transfer. Spleen cells 
from these mice were used as a  combined source of hapten-primed B cells and carrier-primed T 
cells or (after depletion of T  cells as described below) as a  source of hapten-primed B cells. 
KLH  (carrier)-primed mice received 100 t~g KLH on alum plus 2  ×  10  ~" Bordetella pertussis 7 
days  before use as donors in adoptive transfer.  Nylon  wool  column purified spleen cells were 
transferred to provide a  source of carrier-primed T cells when required. 
Depletion  of T  Cells from  Spleen Cell Suspensions.  T  cells were  depleted  from  spleen cell 
suspensions by killing with anti-Thy-1 plus complement in a  '~two-step" killing protocol.  Cells 
were incubated with congenic anti-Thy-1.2 (kindly supplied by Doctors E. A. Boyse and F-W Shen 
at Sloan Kettering Institute for Cancer Research, New York) for 30 rain at 37°C.  After the first 
step, cells were resuspended and incubated with rabbit complement for 30 min at 37°C.  After the 
second step, cells were resuspended and washed once before transfer. 
Adoptive Secondary Response to DNP-KLH.  Donor cells were injected i.v. into semisyngeneic 
BALB/c recipients irradiated (600 R) 18-24 h  before transfer. 
Recipients were challenged i.v. with 10 t~g aqueous DNP-KLH  immediately after transfer.  7 
days later, recipients were killed, their spleens removed,  and DNP-PFC  estimated as described 
below. Since very little (<30%) variability in spleen size, cell yield, or response is usually found 
between individuals in the same group, 3-5 recipients were used per group and their spleen cells 
pooled before plaquing (5,  11, 32). 
Estimation of DNP-PFC in Recipient Spleen.  The PFC assay described by Cunningham and 
Szenberg was used to estimate the number of cells secreting anti-DNP antibody (33). 
Samples of individual or pooled spleen cell suspensions to be tested were mixed with trinitro- 
phenyl-coated burro erythrocytes (34),  frozen and reconstituted guinea pig serum (complement), 
and developing antisera (when desired). Chambers were incubated at 37°C for 1 h and the number 
of DNP-PFC  counted with the  aid of a  dissecting microscope.  Counts from a  minimum of two 
chambers were averaged for each determination. The response is expressed as PFC/106 recipient 
spleen cells.  The  number of indirect PFC  was  determined by  subtracting direct PFC/106  (no 
developing antiserum) from the total PFC/106 found when developing antiserum was included in 
the chamber. In general, the direct PFC response is less than 20% of the total IgG response. 
Antisera for PFC Assay.  Total IgG PFC were developed with a rabbit antiserum reactive with 
all IgG classes.  Specific anti-allotype antisera were used to develop Ig-la and Ig-lb PFC.  Heter- 
oantisera  detecting  Ig-la  and  Ig-lb  were  rendered  specific  by  appropriate  absorptions  with 
insoluble immunoabsorbents (5,  11). The starting serum for anti-Ig-la was produced by immuniz- 
ing  a  goat  with  the  Ig-la  myeloma  protein  5563.  The  starting  serum  for the  anti-Ig-lb  was 
produced by immunizing a rabbit with C75BL/6 (Ig  °) globulins. (This serum was kindly supplied 
by Dr.  John Coe,  Rocky Mountain National Laboratory.) All sera were tested for specificity by 
radioimmune assays and plaque development. 
Preparation and Absorption ofAnti-Ia Sera.  Mice were immunized i.p. with a  suspension of 
spleen and lymph node cells (approximately 1.5 ×  107 cells/mouse). The mice were boosted on days 
28, 35, and 42, and bled on days 49 and 51. Thereafter, animals were reimmunized every 3rd wk 
and bled 7 and 9 days after each booster injection. 
In vitro absorption of antiserum was performed as follows: 1.0 ml of antiserum, diluted 1:5, was 
added to a pellet comprised of spleen and lymph node cells from four mice and incubated for 1 h at 
room temperature. In vivo absorption was done by injecting 0.3 ml of undiluted antiserum i.p. and 
bleeding 3-4 h  later. Table I shows the specificity of antisera used in this study. 
Cytotoxic  Treatment by Anti-Ia.  Cytotoxic treatment was done in a "two-step" killing protocol. 
Cell suspensions were incubated with appropriately diluted anti-Ia for 30 min at 37°C (1-2  ×  107 
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TABLE  I 
Antisera Used in These Studies 
Antisera 
H-2 region incompatibility 
I 
K  ABJ*C  SGD 
Tla incompati- 
bility 
A.TL anti-A.TH 
(B10.A x A.TL)F, anti-B10.HTT 
(B10.T(6R) × B10.D2)F, anti-B10.AQR 
(B10 × HTI)F, anti-B10.A(5R) 
8~$  8  S  8  S 
S  S  S 
kkk 
k  d  d d(?) 
a§ 
* Evidence defining the I-J subregion is presented in an accompanying publication (28). 
$ Haplotype origin of incompatible H-2 regions carried by immunizing strain (16). 
§ Incompatible Tla allele of immunizing strain (35). 
1:12 and incubated for 40 min at 37°C. After passing through a fetal calf serum gradient, the cells 
were used for transfer experiments. 
Results 
Ts  activity  is  assayed  by the  ability  to  suppress  specifically  an  adoptive 
secondary  Ig-lb  allotype  DNP-PFC  response  by  cotransferred  DNP-KLH- 
primed,  syngeneic,  nonsuppressed  spleen  cells.  Nonsuppressed  prime  DNP- 
KLH spleen cells from the allotype heterozygous (Ig~/Ig  b)  (BALB/c  x  SJL)F1 
hybrid mice used in these studies give rise to approximately equal numbers of 
Ig-la and Ig-lb DNP-PFC when transferred without Ts in an adoptive secondary 
assay.  Ts reduce the  Ig-lb response  without affecting  the  Ig-la  or other  IgG 
responses. Therefore, suppression is usually evaluated by comparison of the Ig- 
lb and Ig-la responses in a given group of adoptive secondary recipients. In the 
experiments presented below, the Ts dose (number of suppressed spleen cells) 
used is just slightly greater than the number required to completely suppress 
the Ig-lb response by the primed nonsuppressed cells (32). 
Suppressor T  Cells Carry Surface I-Region Determinants.  Data in Table II 
show that  allotype  Ts  carry  surface  determinants  controlled  by genetic  loci 
within the I  region.  Three/-region  sera which kill Ts are shown in this table. 
One of these antisera, A.TL anti-A.TH, is produced in strains that differ in the 
I,  S,  and  G  regions of the H-2  complex as well as for a  segment of the  17th 
chromosome  which  lies  outside  the H-2  complex and  includes  the  Tla  locus 
(Table  I).  The  other  two  antisera,  (B10.A  x  A.TL)F1  anti-B10.HTT  and 
(B10.T(6R)  x  B10.D2)F1  anti-B10.AQR,  are  made  between  congenic  strains 
which differ only for determinants  controlled by a  portion of the I  region.  The 
ability of these latter  sera to kill Ts places the control  of a  set of Ts surface 
determinants clearly within the I  region. 
Evidence that a fourth/-region antiserum  (B10 x  HTI)F1 antiB10.A(5R) does 
not kill Ts is also presented in Table II. This serum (see below) kills helper T 
cells required for an IgG adoptive secondary response./-region haplotype differ- OKUMURA,  HERZENBERG,  MURPHY,  McDEVITT,  AND  HERZENBERG  689 
TABLE II 
Removal of Suppressor T-Cell Activity  by Anti-I-Region  Sera 
(BALB/c  × SJL)F, 
spleen cells  transferred 
(x I06) 
DNP-KLH  Ig-lb sup- 
pressed 
primed  spleen (Ts) 
Treatment of Ts*  Indirect DNP-PFC/106$ 
Antiserum  Ig-lb  Ig-la  Total IgG 
Result:  Ts 
gone 
-  215  301  2,540 
NMS  <:10  266  2,010  No 
A.TL anti-A.TH  191  231  1,760  Yes 
(B10,A x  A.TL)F~  201  271  2,810  Yes 
anti-B10.HTT 
(BIO.T(6R)  x BI0,D2)F,  186  216  2,000 
anti-Bl0,AQR 
Yes 
(BI0 x HTI)F,  <:i0  313  2,820  No 
anti-Bl0.A(SR) 
*  For/-region  specificity:  see Table I. Treatment was done with antiserum plus complement. Final dilution  of  anti-la  sera was 1:5. 
Number  of treated cells  transferred equals remainder after treatment of indicated cell  number.  For details of treatment and 
adoptive transfer, see Materials and Methods section. 
Indirect DNP-PFC/10 s  recipient spleen cells.  Direct DNP-PFC  (<::30)  subtracted. 
ences between the strains used to prepare this serum (see Table I) indicate that 
it  should  also contain antibody against  the determinants present on Ts.  Its 
failure to kill Ts apparently reflects biological variability in the response to the 
immunizing Ia antigens.  (We have seen similar variability with respect to Th 
kill, where one pool ofA.TL anti-A.TH kills Th and another does not, although 
both pools kill Ts.) 
Data in Table III show that complement is required for removal of Ts activity. 
This demonstrates that the/-region antisera are killing rather than inactivat- 
ing (blocking) a cell required for Ts activity. Data in this table also demonstrate 
that Ts are the direct targets of the/-region antisera cytotoxicity. The ability of 
/-region antisera to kill nylon column purified spleen Ts cells rules out indirect 
killing  as  the result  of massive  B-cell death; and the failure of anti-Thy-1- 
treated (T-depleted) spleen cells from suppressed mice to restore the Ts activity 
removed by cytotoxic treatment of the nylon-purified cells with/-region antisera 
demonstrates that these antisera are killing the Thy-1 positive cells responsible 
for suppression, i.e., Ts. 
Normal Lymphoid Cells Carry The I-Region Determinants Detected on Allo- 
type Suppressor  T  Cells.  The cytotoxic activity of/-region antisera against 
(BALB/c x  SJL)F, allotype suppressor T cells (Ts) provides clear evidence that 
the determinants detected are not restricted to these cells, since (a) the lymph- 
oid cells used to raise the antisera came from donor strains which would not be 
expected to show allotype suppression of the type seen in  (BA1B/c  x  SJL)F, 
hybrids, and (b) the donors were not given the exposure to anti-allotype antisera 
required for the induction of allotype Ts. One of the immunizing donor strains 
(A.TH) does not even carry the Ig-lb  allele whose product is suppressed by 
allotype Ts.  Thus,  unless allotype Ts are a  constituent population in normal 
lymphoid tissues, the/-region determinants found on allotype Ts are carried by 
other lymphoid cells as well. 690  I-REGION  DETERMINANTS  ON  HELPER  AND  SUPPRESSOR  T  CELLS 
TABLE  III 
Removal of Suppressor  T-Cell Activity by Anti-I-Region A ntisera: Complement 
Dep'endence, Failure of T-Depleted Suppressor  Populations  to Restore Activity 
(BALB/c × SJL)F,  Indirect DNP-PFC/ 
spleen cells trans-  Treatment  of Ts  106§ 
ferred ( × 10  ~) 
DNP-  Ig-lb 
KLH  sup- 
primed  pressed 
Ts* 
Antiserums  C'  Ig-lb  Ig-la 
Result: 
Ts gone 
8 
"  1.5 
-  112  149 
NMS  +  18  141  No 
A.TL anti-A.TH  +  87  102  Yes 
"  -  <10  131  No 
(B10.A × A.TL)F~  +  96  147  Yes  anti-B10.HTT 
"  -  <10  103  No 
8  1.5  ATL anti-A.TH 
plus 107 T-depleted[[ 
(B10.A x A.TL)F, 
+  99  121  Yes 
Anti-HTT  +  101  138  Yes 
plus 107 T depleted 
*  Nylon wool column purified T cells were used as a source of Ts. 
SFinal dilution of anti-Ia antisera  used in this experiment was 1:5. Number of cells transferred 
equals remainder after treatment of indicated cell number. For details of treatment and adoptive 
transfer,  see Materials and Methods section. 
§  Indirect DNP-PFC/10  ~  recipient spleen cells. Direct DNP-PFC (<20) subtracted. 
II T depleted: suppressed  spleen cells added after  treatment  as  a  source of potential  "non-T" 
cells required for suppression. T cells were depleted by anti-Thy 1.2 complement using silicon- 
ized glassware to prevent depletion of glass adherent cell populations. 
The same point is demonstrated by in vivo and in vitro absorption studies with 
normal  nonsuppressed  animals.  Cytotoxic activity  for Ts  was  completely re- 
moved from the three/-region antisera described above by absorption with the 
immunizing strain or strains carrying the same/-region haplotypes. No activity 
was removed by absorption with the serum donor strain or strains carrying the 
same/-region haplotype, thereby demonstrating the specificity of these sera for 
/-region  determinants  (18,  28).  In  the  representative  absorption  experiment 
shown in Table IV, (B10.A ×  A.TL)F1 anti-B10.HTT was absorbed in vitro with 
spleen cells from B10.A and B10.HTT. B10.A, one of the parental strains in the 
serum producer, absorbed no cytotoxic activity, while B10.H2~I  ~, the immunizing 
strain,  was able to absorb all  the  activity.  The absorptions demonstrate that 
mouse strains  of the  appropriate  haplotype have  lymphoid cells carrying the 
same determinants found on allotype Ts. 
Data  presented  elsewhere  (28)  show that  the  Ts/-region determinants  are 
present on T but not B cells; and data presented here show that at least some of 
theI-region determinants detected on Ts are not present on helper T cells. Thus, 
these determinants mark a  subset T lymphocytes which, in allotype-suppressed OKUMURA,  HERZENBERG,  MURPHY,  McDEVITT,  AND  HERZENBERG 
TABLE  IV 
Absorption  of Anti-Suppressor T-Cell Activity with Normal Lymphoid Cells 
691 
(BALB/c  x SJL)F, spleen 
cells  transferred (  ×  I0  ~) 
Treatment of Ts*  Indirect DNP-PFC/10s$ 
DNP-KLH  Ig-lb sup-  In vitro absorp- 
pressed  Antiserum  Ig-lb  Ig-la 
primed  spleen (Ts)  tion 
Result: Ts 
gone 
-  1,160  1,100 
NMS  -  147  1,080  No 
(B]0.A x A.TL)F,  1,120  1,220  Yes 
anti-B10.HTT 
BIO,A  1,110  1,200  Yes 
BI0.HTT  127  1,080  No 
*For f-cegion specificity: see Table I. Treatment was done with antiserum plus complement. Absorption of antisera was performed 
in vitro with spleen and lymph node cells.  Final dilution of anti-Ia sera was 1:5.  Number of treated  cells transferred equals 
remainder after treatment of indicated cell number. For details of treatment and adoptive transfer, see Materials and Methods 
section. 
$1ndirect DNP-PFC/10  s recipient spleen cells.  Direct DNP-PFC (<200) subtracted. 
mice, contains the allotype suppressor T  cell. Whether the T  cells in normal 
mice  which bear  the  Ts/-region  determinants  are  also  suppressor  T  cells, 
perhaps generated in response to environmental or self-antigens, remains to be 
determined. 
Helper T Cells Carry I-Region Determinants.  Th activity in these studies is 
measured in  a  "homologous" adoptive  secondary antibody response to  DNP. 
DNP-KLH-primed spleen cells treated with anti-Thy-l.2 plus complement are 
used as a  source of DNP-primed B cells. These cells are cotransferred with Th 
(KLH-primed spleen cells) untreated or pretreated with/-region antisera plus 
complement. The Th dose is chosen such that the splenic IgG DNP-PFC  re- 
sponse in recipients of untreated Th is proportional to the amount of Th activity 
injected (i.e., the Th dose limits the response). Donors are (BALB/c x  SJL)F, 
hybrids. Recipients are irradiated (600 R) BALB/c. 
Three sera containing/-region antibody were found which kill Th (see Table 
V).  One of these sera,  (B10.T(6R)  x  B10.D2)F,  anti-B10.AQR,  was produced 
between congenic strains  differing only within  the I  region,  indicating that 
surface determinants detected on Th are controlled by loci within this segment. 
Furthermore, since the strains used to prepare this serum differ only in the I-A, 
I-B, and I-J (Table I) subregions, the loci controlling the Th determinants must 
map to one of these subregions. 
Th  activity  is  also  removed from  carrier-primed  nylon-passed T  cells  by 
treatment with anti-I-region sera. This suggests that Th killing by these anti- 
sera (like Ts killing) is not due to the concomitant death of large numbers of Ia 
positive B cells (see Table VI). Data in the same table also show the titration of 
A.TL anti-A.TH cytotoxic activity for Th, and that removal of Th activity is 
complement dependent. This Th killing activity is removed from the antisera by 
in vivo absorption with normal (unprimed) animals of the appropriate haplotype 
(18). 
In both of these experiments, as in all other Th removal experiments, DNP- 
KLH-primed B cells treated with congenic anti-Thy-1 to remove endogenous 
Thy-i positive helper cells were used as the source of hapten-primed B cells. 
These Thy-l-depleted spleen cell populations should supply all other types of 692  I-REGION  DETERMINANTS  ON  HELPER  AND  SUPPRESSOR  T  CELLS 
TABLE  V 
Removal of Helper Activity  by Anti-I-Region  Sera 
(BALB/c x  SJL)F~ spleen cells trans- 
ferred (x  10  ~) 
Treatment of Th$ 
DNP-KLH  Total indirect 
KLH-  DNP-PFC/106§ 
primed T-  Exp. no.  primed  Antiserum 
depleted 
(B)*  spleen (Th) 
5  -  -  125 
"  8  NMS  3,960 
"  4  NMS  2,290 
....  A.TL anti-A.TH  417 
4  -  -  219 
~'  4  NMS  1,610 
....  A.TL anti-A.TH  318 
(B10.A  x  A.TL)F~  1,770 
anti-B10.HTT 
(B10.T(6R)  x  B10.D2)FI  322 
anti-B10.AQR 
(B10  x  HTI)F1  415 
anti-B10.A(5R) 
*T cells were depleted by treatment with anti-Thy-l.2 plus complement. 
$Indirect DNP-PFC/106 recipient spleen cells. Direct (<40) subtracted. 
§  For/-region specificity: see Table I. Treatment was done with antiserum plus complement. Final 
dilution of anti-Ia sera used was 1:5. Number of treated cells transferred equals remainder after 
treatment of indicated cell number. For details of treatment and adoptive transfer, see Materials 
and Methods section. 
TABLE  VI 
Titration of I-Region Sera for Removal of Helper T-Cell Activity 
(BALB/c x  SJL)F, spleen 
cells transferred (x  10  G) 
DNP-KLH 
primed T-  KLH 
depleted  primed Th$ 
(B)* 
Treatment of Th§ 
Antiserum  Dilution 
Total indirect 
DNP-PFC/10~II 
5 
~  2 
-  -  146 
NMS  1:5  2,210 
A.TL anti-A.TH  1:5  547 
"  1:10  988 
"  1:20  2,360 
"¶  1:5  1,950 
* T cells were depleted by treatment with anti-Thy-l.2 plus complement. 
Nylon wool column purified T cells were used a source of Th. 
§ For/-region specificity: see Table  I.  Treatment was done with antiserum plus  complement. 
Number of treated cells transferred equals remainder after treatment of indicated cell number. 
For details of treatment and adoptive transfer Materials and Methods section. 
II Indirect DNP-PFC/10  ~ recipient spleen cells. Direct (<40) subtracted. 
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cells required for the adoptive secondary response. Therefore, the removal of Th 
activity by  I-region antisera demonstrates that these sera kill the Thy-1 positive 
cells which help IgG responses, i.e., helper T cells. 
The removal of Th activity by the I-region antisera used here is considerably 
less effective  than the removal of Ts. To detect a loss of  Th activity, the Th assay 
had to be optimally sensitive, i.e., the Th dose used had to limit the response. 
We have shown in other studies (unpublished) that even a twofold excess of Th 
activity virtually obscures  the  measurable reduction of Th  activity  due  to 
cytotoxic treatment of the Th with I-region antisera. This is consistent with 
evidence that shows that Th killing by these antisera is incomplete under the 
conditions we use (see Table V). 
Reports by H~immerling et al. (21) and Press (in reference 15) have appeared 
indicating that I-region antisera do not kill Th. Differences in antisera, mouse 
strains,  or assay conditions could account for the discrepancy between these 
results and ours.  In particular, we measure helper activity by transfer of F1 
hybrid cells into one of the parental strains (BALB/c). Although the recipient is 
sufficiently irradiated (600 R) so that the graft survives indefinitely in over 95% 
of recipients, there appears to be an incompatibility Cback-stimulation") reac- 
tion which increases the PFC response approximately two to threefold over that 
obtained by transfer in syngeneic hybrid recipients (Herzenberg, unpublished 
observation).  This  augmentation is not due to T-cell replacement due to an 
allogeneic effect since primed helper cells are required to obtain a  DNP-PFC 
response in this transfer system. The augmentation may, however, be important 
in allowing the demonstration of Th removal by I-region antisera. 
The reduction in Th activity reported here could in fact be due to interference 
with the augmentation mechanism rather than to direct removal of Th, i.e., the 
residual Th activity we observe after treatment withI-region sera could actually 
be the Th activity measurable under nonaugmentation conditions. The consist- 
ent removal of 80% or more of the Th activity observed after antiserum treat- 
ment argues against this possibility, since the residual Th activity appears to be 
significantly less than would be expected in the absence of augmentation. Work 
is in progress to conclusively resolve this problem. At present, it is not clear 
whether the type of Th activity removed is demonstrable only in the adoptive 
transfer assay used in our studies or also can be identified in the usual syngeneic 
transfer system. 
Selective Expression of Determinants on Helper and Suppressor T Cells.  We 
have shown in the preceding sections that one of the antisera which kills Ts, 
(B10.A  x  A.TL)F, anti-B10.HTT, does not kill Th (see Tables III and V). This 
demonstrates that Ts carry/-region determinants not found on Th. 
Our studies also show that Th carry determinants not found on Ts, since one 
of the antisera which kills Th, (B10 x  HTI)F1 anti-B10.A(SR),  does not kill Ts. 
This antiserum, however, is produced in strains that differ not only in the I 
region, but also in the S and possibly G regions of the H-2 complex (see Table I). 
Thus, we cannot conclude that the Th determinants it detects are definitely 
controlled within the I  region.  Data with another antiserum,  (B10.T(6R)  x 
B10.D2)F1 anti-B10.AQR, demonstrate clearly that Th do carry I-region deter- 
minants (see Table V). This antiserum, however, also kills Ts, and therefore, 
could be detecting the same I-region determinants on Ts and Th. Nevertheless, 694  I-REGION  DETERMINANTS  ON  HELPER  AND  SUPPRESSOR  T  CELLS 
the most economical interpretation of the data obtained with these two antisera 
suggests that Th carry/-region determinants which are not present on Ts. 
Discussion 
The detection of  I-region determinants on Th and Ts provides a new tool for 
studying the cellular interactions which regulate immune responses.  It  also 
provides some interesting new insights into the role of the/-region itself in 
immunoregulation. 
We have shown elsewhere that the/-region determinants on Ts are controlled 
by a locus, Ia-4, separable by crossing over from the loci which control/-region 
(Ia) determinants on B cells (28). This locus marks a new subregion,/-J, located 
between the I-B and I-C subregions. It also contains loci (possibly the same as 
Ia-4) which code for determinants on the T cells which initiate (promote) Con A 
responsiveness (Frelinger, personal communication) and for determinants on 
the T cells and soluble factors which suppress antibody responses dependent on 
KLH for carrier function (27). 
Ia-4 determinants do not appear to be restricted to allotype Ts, since spleen 
cells from nonsuppressed mice were used both to generate and to absorb the 
anti-Ia-4 antibody. Nevertheless, these determinants are restricted to a subpop- 
ulation ofT lymphocytes. Absorption studies presented elsewhere (28) show that 
B cells do not carry Ia-4 determinants although T cells do; and data presented 
here show that Ts, but not Th, carry Ia..4.  (If Ts and Th carry shared/-region 
determinants these would have to be controlled by a  separate locus, assuming 
one locus per gene product.) Thus Ia-4 determinants are carried on a subset of T 
lymphocytes, including allotype Ts. 
Th also carry H-2-controlled determinants restricted to a subset of T lympho- 
cytes.  As we have shown here,  an antiserum that kills Th does not kill Ts; 
therefore, the Th determinants define a T-cell subset which does not include Ts. 
Whether these determinants on Th are controlled by the I, S, or G subregions 
and whether they are different from the Ia determinants on B cells remains to be 
determined. The evidence that Th definitely carry/-region determinants sug- 
gests that the locus that controls the unique Th determinants are in the/-region. 
The Ly surface antigens also identify distinct T-cell subsets containing Ts (Ly- 
2) or Th (Ly-1); however, the Ly-2 subset apparently contains more functionally 
identifiable cells than  those  contained within  the  Ia-4-bearing  subset.  This 
subdivision of Ly-2 cells into Ia-4 positive or negative bears on the question of 
whether Ts  are cytotoxic T  cells.  Cytotoxic precursor and effector cells,  like 
allotype Ts, are Ly-2 (2); however, in contrast to allotype Ts, cytotoxic precur- 
sors and effector cells do not appear to carry/-region surface determinants (21). 
If the same pools ofI-J antisera used here to kill Ts fail to kill (BALB/c × SJL)F~ 
cytotoxic cells, then evidence for a subdivision of Ly-2 cells will be complete. As 
a corollary, this would demonstrate that the mechanism of allotype suppression, 
i.e., allotype Ts removal of Th activity (Ig-lb Th) which helps Ig-lb memory B 
cells (5, 32), does not involve killing by cytotoxic T cells such as those responsi- 
ble for cellular immunity (36). 
Other evidence also suggests that removal ofIg-lb Th activity by Ts is not due 
to  cytotoxic killer cells.  Cultured spleen cells from allotype-suppressed mice OKUMURA,  HERZENBERG,  MURPHY,  McDEVITT,  AND  HERZENBERG  695 
produce a  soluble suppressive factor  (TsF)  which specifically removes Ig-lb 
helper activity. Carrier-primed spleen cells cultured for 24 h in the presence of 
TsF lose virtully all Ig-lb Th activity detectable in the adoptive transfer assay 
although other Th activity is unaffected (5). Serum from suppressed mice also 
contains  TsF  activity  (unpublished observation).  Thus  allotype suppression 
appears  to  be  mediated, at  least  in  part,  by TsF.  Cytotoxic killer cells,  in 
contrast, appear to kill by direct cell-to-cell contact (26). 
The presence of/-region determinants on Th  and Ts provides a  different 
framework for consideration of the mechanism of suppression. The location of 
the loci coding for these determinants in close proximity to the Ir loci which 
control immune responsiveness to a variety of antigens suggests that the Ts and 
Th determinants may in general play a role in immunoregulation. This thesis is 
considerably strengthened by the  demonstration that  soluble factors,  which 
mediate suppression (26) or help (15, 24, 25), carryI-region determinants and by 
evidence that specific immune suppression (Is) genes map in the/-region (37, 
38). Although the evidence is still too fragmentary to allow clear definition of the 
role of these determinants, the existing data are consistent with their being part 
of the regulatory language used for communication among responding lympho- 
cytes. 
For example, in allotype suppression three cells make up a basic network: Ig- 
lb memory cells which give rise to Ig-lb afc, Ig-lb Th which are required for the 
differentiation and expansion of Ig-lb memory cells to afc, and Ig-1  b Ts which 
remove Ig-lb Th activity (5). How Ig-lb allotype Ts recognize the Ig-lb Th is 
unknown; however, as indicated above, Ig-lb Th activity can be removed from 
carrier-primed spleen cells by pretreatment with a TsF produced by Ts contain- 
ing spleen cells.  At least one of the cells in this network (Ts)  is marked by 
unique/-region determinants. The other two cells  (Th and B) carry/-region 
determinants which may  (or  may  not)  be  shared;  however,  Th  carry H-2- 
controlled determinants (probably/-region) which are not present on Ts. 
Tada  has  described what  may be  a  similar network regulating antibody 
responses to KLH and haptens coupled to KLH. These studies directly implicate 
I-J subregion determinants (not necessarily Ia-4) in what appears to be a TsF- 
mediated interaction between Ts and Th. Tada and co-workers have shown (a) 
that KLH-specific Ts carry surface I-J determinants (personal communication); 
(b) that soluble suppressive factors  (KLH-TsF) extracted from Ts-containing 
thymus or spleen also carry I-J determinants (27); and (c) that effective suppres- 
sion with KLH-TsF requires the presence of  I-region-encoded receptors for KLH- 
TsF on the responding (target) strain T (but not B) cells (39). 
Tada has not yet directly determined whether KLH-TsF removes Th activity. 
We have not yet determined whether allotype TsF carries I-J determinants. But 
the similarities between the two systems suggest that at this point the informa- 
tion gathered should be integrated for consideration of overall mechanisms of 
regulation of antibody production. The results of such "integration" suggest to 
us that Ts produce soluble factors which kill or inactivate Th; and that I-J 
determinants on the soluble factors are involved in the recognition (removal) of 
the target Th. Thus the selective expression of I-region determinants on cells 
and factors involved in antibody production appears to be an integral part of the 
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Summary 
Data presented here show that loci in the/-region of  the H-2 gene complex are 
selectively expressed in different functional T-cell subpopulations. These loci 
are closely linked (or possibly identical) to loci that control immune responses. 
They control  surface  determinants which  identify helper  and  suppressor  T 
lymphocytes. 
Determinants described here on allotype suppressor T cells (Ts) are found on 
normal (nonsuppressed) lymphoid cells, but are not found on helper T cells (Th). 
These determinants are controlled by a locus mapping in the I region of the H-2 
complex. In an accompanying  publication we show that this locus (Ia-4) marks a 
new I  subregion (I-J) and is expressed only on T cells. Thus Ia-4 determinants 
identify a T-cell subpopulation which includes Ts but not Th. 
Th also carry identifying surface determinants controlled by loci that map to 
the H-2  complex, probably within the I  region.  These determinants are  not 
found on Ts.  Data presented  also establish that loci in the I  region control 
determinants on Th, but do not conclusively demonstrate that these are the 
determinants that distinguish Th from Ts. 
The selective expression of H-2-controlled determinants on Ts and Th sug- 
gests that these determinants are directly involved in immunoregulation. 
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